Botanix Pharmaceuticals Limited
Botanix Pharmaceuticals Limited, often referred to simply as Botanix, is an innovative biopharmaceutical company headquartered in Australia. Founded in 2016, the company focuses on developing novel therapies for skin diseases and other medical conditions, leveraging the therapeutic potential of cannabinoids. With a strong operational presence in Australia and the United States, Botanix is at the forefront of cannabinoid-based medicine. The company’s core products include its proprietary formulations designed to treat conditions such as acne and psoriasis, setting it apart in the competitive dermatology market. Botanix has achieved significant milestones, including successful clinical trials that underscore its commitment to advancing cannabinoid research. With a growing portfolio and a focus on scientific excellence, Botanix Pharmaceuticals is positioned as a leader in the emerging field of cannabinoid therapeutics.
DitchCarbon Score
How does Botanix Pharmaceuticals Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Botanix Pharmaceuticals Limited's score of 9 is lower than 94% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Botanix Pharmaceuticals Limited's reported carbon emissions
Botanix Pharmaceuticals Limited, headquartered in Australia, currently does not have any publicly available carbon emissions data or specific reduction targets. As such, there are no reported figures for their carbon emissions in kg CO2e, including Scope 1, 2, or 3 emissions. In the absence of specific emissions data, it is important to note that the company may still be engaged in various climate commitments or initiatives typical within the pharmaceutical industry. However, without concrete information on their climate strategies or pledges, it is difficult to assess their environmental impact or sustainability efforts. As the industry increasingly focuses on reducing carbon footprints and enhancing sustainability, Botanix Pharmaceuticals Limited may be expected to align with these trends in the future.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Botanix Pharmaceuticals Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
